Ecoclindin (Clindamycin 100 mg) is a prescription intravaginal antibiotic specifically formulated for the treatment of bacterial vaginosis (BV). It combines the proven antibacterial activity of clindamycin with lactulose — a natural prebiotic — that actively promotes the restoration of healthy vaginal lactobacilli, making Ecoclindin a uniquely complete therapeutic solution.
Unlike standard clindamycin preparations, Ecoclindin's innovative dual-action formula addresses both the infection and the underlying vaginal microbiome imbalance. This results in superior microbiome recovery rates and a significantly reduced risk of recurrence.
✔ Clinically Proven Efficacy
97.5% pathogen eradication confirmed by real-time PCR (Femoflor-16) at Day 4 in a prospective multicenter clinical trial.
✔ Lowest Recurrence Rate
Only 7.5% BV recurrence at Day 30, compared to 20.0% with standard clindamycin alone (p = 0.0002).
✔ Microbiome-Restoring Formula
Lactulose prebiotic selectively stimulates Lactobacillus regrowth — 87.5% of patients achieve full microbiome normalisation by Day 18.
✔ Excellent Safety Profile
Ecoclindin Advantage
Lactulose prebiotic actively promotes regrowth of beneficial Lactobacillus species, unlike standard clindamycin alone.
+42.5% more patients with full Lactobacilli normalisation (Day 18) vs. clindamycin-only comparator (p=0.0002).
